Cluster C
COPD and effects (positive and negative) of systemic treatments
- Treatment with Quinine and the risk of exacerbations and mortality in patients with chronic obstructive pulmonary disease
- Use of amlodipine and the risk of hospitalization requiring COPD exacerbation
- Beneficial and harmful effects of treatment with promethazine in patients with COPD – a Danish nationwide register study
- D-dimer in COPD out-patients: Distribution, association with mortality and effect modification by anticoagulant therapy
- Risk of increased mortality and cardiovascular events in patients with COPD treated with clarithromycin
- Calcium supplement for COPD patients – Cardiovascular risk- KALKOL
- Risk of pneumonia and death in outpatients with chronic obstructive pulmonary disease treated with different lengths of corticosteroids
- Observational cohort study of the risk of acute exacerbations in patients with COPD receiving anticoagulative treatment
- ACE inhibitors and Angiotensin II receptor blockers in the treatment of COPD (protocol in danish)
- Methotrexate and the risk of admissoin for COPD exacerbation in patients with severe COPD and concurrent rheumatic disease
- Oral corticosteroid and the risk for major cardiovascular events among patients with chronic obstructive pulmonary disease, a Danish registry-based cohort study
